We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
MXC.AU

Price
-
Stock movement up
+- (%)
Company name
MGC Pharmaceuticals Ltd
Exchange
(AU
,
Currency
AUD
)
Sector
Healthcare >
Drug Manufacturers-Specialty & Generic
Market cap
1.39B
Ent value
1.40B
Price/Sales
299.14
Price/Book
125.73
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-4.14%
1 year return
5087.50%
3 year return
90.53%
5 year return
59.66%
10 year return
-6.12%
Last updated: 2024-12-17

DIVIDENDS

MXC.AU does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales299.14
Price to Book125.73
EV to Sales301.24

FINANCIALS

Per share

Per share data
Current share count3.35B
EPS (TTM)-0.01
FCF per share (TTM)-0.01

Income statement

Income statement data
Revenue (TTM)4.65M
Gross profit (TTM)1.63M
Operating income (TTM)-16.95M
Net income (TTM)-16.77M
EPS (TTM)-0.01
EPS (1y forward)-0.07

Margins

Margins data
Gross margin (TTM)35.15%
Operating margin (TTM)-364.73%
Profit margin (TTM)-360.79%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash1.79M
Net receivables3.35M
Total current assets7.36M
Goodwill5.38M
Intangible assets5.38M
Property, plant and equipment0.00
Total assets22.60M
Accounts payable2.50M
Short/Current long term debt2.29M
Total current liabilities7.02M
Total liabilities11.54M
Shareholder's equity11.06M
Net tangible assets6.23M

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-12.16M
Capital expenditures (TTM)2.69M
Free cash flow (TTM)-14.85M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-151.64%
Return on Assets-74.18%
Return on Invested Capital-149.60%
Cash Return on Invested Capital-132.52%

STOCK INFORMATION

Downside potential

Downside potential data
MXC.AUS&P500
Current price drop from All-time high-80.27%-2.51%
Highest price drop-99.95%-56.47%
Date of highest drop12 Oct 20239 Mar 2009
Avg drop from high-94.77%-11.07%
Avg time to new high2592 days12 days
Max time to new high2591 days1805 days
COMPANY DETAILS
MXC.AU (MGC Pharmaceuticals Ltd) company logo
Marketcap
1.39B
Marketcap category
Small-cap
Description
MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.
Employees
0
Website
https://mgcpharma.com.au
Investor relations
-
SEC filings
MXC.AU SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
All newsPress releases
No items found
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved